Skip to main content
OpenTrials

Clinical trial condition

Urogenital Diseases

Explore clinical trials studying Urogenital Diseases. Study availability and eligibility vary by location and protocol.

40,124 public trials 6,115 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Diseases trial results

Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

NCT07567846

Conditions
Advanced Prostate Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • St Vincent's Hospital Sydney Darlinghurst, New South Wales, Australia
  • Austin Hospital Heidelberg, Victoria, Australia
View Trial Details
Recruiting

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

NCT07198074

Conditions
Advanced Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
View all 267 locations
View Trial Details
Recruiting

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

NCT04447911

Conditions
Brain Diseases, Central Nervous System Diseases, Digestive System Diseases, +21 more
Locations
  • University Hospital of Würzburg, med. Poliklinik Würzburg, Germany
  • Erasmus Universität Medisch Centrum Rotterdam, Department of Internal Medicine Rotterdam, Netherlands
  • Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland
  • University Hospital Basel Basel, Switzerland
View Trial Details
Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details
Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

NCT07144319

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Oslo University Hospital Oslo, Norway
View Trial Details

Related conditions